{"id":"succinimide","brandName":"succinimide","genericName":"succinimide","companyId":"unknown","companyName":"","phase":"unknown","status":"active","modality":"","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"Succinimide is a small molecule organic compound with the formula (CH2)2(CO)2NH, classified as a cyclic imide. It is used in various organic syntheses and industrial processes, such as silver plating.","enrichmentLevel":3,"visitCount":0,"mechanism":{"target":"Protein cereblon, Cereblon isoform 4"},"administration":{},"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":["NCT01278004","NCT02973542","NCT04047394","NCT01122381","NCT04431778","NCT03887624","NCT00689585","NCT00088452","NCT03196466","NCT04274179","NCT02205931","NCT04217733","NCT02100046"],"indications":{"approved":[{"name":"Primary hyperoxaluria","diseaseId":"primary-hyperoxaluria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[{"nctId":"NCT01278004","phase":"Phase 2","title":"A Randomised Double-blind Placebo-controlled Trial of the Safety and Efficacy of Ethosuximide 250mg Capsules for the Management of Chemotherapy Induced Painful Peripheral Neuropathy","status":"COMPLETED","sponsor":"Royal Marsden NHS Foundation Trust","isPivotal":false,"enrollment":15,"indication":"Cancer, Peripheral Neuropathy","completionDate":"2014-07"},{"nctId":"NCT02973542","phase":"Phase 2","title":"Evaluation of the Efficacy and Tolerance of Ethosuximide in the Treatment of Abdominal Pain Associated With Irritable Bowel Syndrome","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","isPivotal":false,"enrollment":162,"indication":"Irritable Bowel Syndrome","completionDate":"2023-05"},{"nctId":"NCT04047394","phase":"Phase 1","title":"An Open Label, Single-dose, Dose-increasing Study to Assess the Safety, Tolerability, PK and Preliminary PD of PEGylated Recombinant Candida Urate Oxidase (SSS11) for Injection in Chinese Healthy Adul","status":"UNKNOWN","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","isPivotal":false,"enrollment":33,"indication":"Gout","completionDate":"2022-12-30"},{"nctId":"NCT01122381","phase":"Phase 1","title":"Pharmacologic and Genetic Evaluation of a C. Elegans Model for Migraine","status":"TERMINATED","sponsor":"US Department of Veterans Affairs","isPivotal":false,"enrollment":5,"indication":"Headache, Migraine","completionDate":"2014-04"},{"nctId":"NCT04431778","phase":"Phase 2","title":"Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","isPivotal":false,"enrollment":64,"indication":"Peripheral Neuropathic Pain","completionDate":"2023-12-31"},{"nctId":"NCT03887624","phase":"EARLY/Phase 1","title":"A Randomized, Parallel-group，Placebo-controlled, Double-blind Clinical Trial to Evaluate the Efficacy and Safety of Ethosuximide in Chinese Patients With Treatment-Resistant Depression.","status":"COMPLETED","sponsor":"Zhejiang University","isPivotal":false,"enrollment":16,"indication":"Depressive Disorder, Treatment-Resistant","completionDate":"2021-04-01"},{"nctId":"NCT00689585","phase":"Phase 2","title":"A Single Centre. Parallel-Group, Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial on Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","isPivotal":false,"enrollment":4,"indication":"Complex Regional Pain Syndromes","completionDate":"2010-07"},{"nctId":"NCT00088452","phase":"Phase 3","title":"Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","isPivotal":true,"enrollment":453,"indication":"Childhood Absence Epilepsy, Petit Mal Epilepsy","completionDate":"2016-08-31"},{"nctId":"NCT03196466","phase":"N/A","title":"Population Pharmacokinetics of Antiepileptic in Pediatrics","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","isPivotal":false,"enrollment":753,"indication":"Epilepsy","completionDate":"2023-06-15"},{"nctId":"NCT04274179","phase":"Phase 3","title":"A Prospective, Case-control Evaluation of Ketogenic Dietary Therapy for New-onset Childhood Absence Epilepsy","status":"RECRUITING","sponsor":"Johns Hopkins University","isPivotal":true,"enrollment":40,"indication":"Absence Epilepsy, Ketogenic Dieting","completionDate":"2026-05-01"},{"nctId":"NCT02205931","phase":"Phase 4","title":"A Randomised Controlled Trial of the Ketogenic Diet in the Treatment of Epilepsy in Children Under the Age of Two Years","status":"UNKNOWN","sponsor":"University College, London","isPivotal":false,"enrollment":160,"indication":"Epilepsy","completionDate":"2019-06"},{"nctId":"NCT04217733","phase":"Phase 3","title":"A Comparative Study to Assess Safety and Effectiveness of Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"Tanta University","isPivotal":true,"enrollment":60,"indication":"IBS - Irritable Bowel Syndrome","completionDate":"2030-12-30"},{"nctId":"NCT02100046","phase":"Phase 2","title":"Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","isPivotal":false,"enrollment":114,"indication":"Neuropathic Traumatic Pain, Pain NRS ≥ 4","completionDate":"2017-01-01"}],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}